Revance Therapeutics (NASDAQ:RVNC) Rating Reiterated by Needham & Company LLC
MarketBeatNeedham & Company LLC reissued a “hold” rating on shares of Revance Therapeutics in a research note on Monday.
Needham & Company LLC reissued a “hold” rating on shares of Revance Therapeutics in a research note on Monday.